HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $75,000 | -29.2% | 8,420 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $106,000 | -68.7% | 8,420 | -53.0% | 0.00% | -62.5% |
Q1 2022 | $339,000 | -46.1% | 17,920 | 0.0% | 0.01% | -38.5% |
Q4 2021 | $629,000 | -4.1% | 17,920 | 0.0% | 0.01% | -13.3% |
Q3 2021 | $656,000 | -6.8% | 17,920 | 0.0% | 0.02% | +7.1% |
Q2 2021 | $704,000 | +39.1% | 17,920 | 0.0% | 0.01% | +40.0% |
Q1 2021 | $506,000 | -11.8% | 17,920 | 0.0% | 0.01% | -16.7% |
Q4 2020 | $574,000 | -0.9% | 17,920 | 0.0% | 0.01% | -7.7% |
Q3 2020 | $579,000 | +47.7% | 17,920 | +26.1% | 0.01% | +30.0% |
Q2 2020 | $392,000 | +143.5% | 14,207 | +57.7% | 0.01% | +150.0% |
Q1 2020 | $161,000 | +36.4% | 9,007 | +91.4% | 0.00% | +33.3% |
Q4 2019 | $118,000 | -75.8% | 4,707 | -82.7% | 0.00% | -72.7% |
Q3 2019 | $487,000 | -26.8% | 27,276 | -9.7% | 0.01% | -26.7% |
Q2 2019 | $665,000 | -52.2% | 30,212 | -33.5% | 0.02% | -51.6% |
Q1 2019 | $1,390,000 | +32.5% | 45,448 | 0.0% | 0.03% | +19.2% |
Q4 2018 | $1,049,000 | – | 45,448 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |